Employers Could Reap Substantial Savings Through Biosimilars, But Not Without Targeted Effort

August 23, 2019Filed Under: NewsBy admin

“A new report from Matrix Global Advisors and the National Business Group on Health, sponsored by Boehringer Ingelheim, shows that employers could see substantial savings from biosimilars, but those savings won’t come without a concerted effort to encourage biosimilar use.”

New MGA Paper Estimates Biosimilar Savings Opportunities for Large Employers

August 19, 2019Filed Under: AnalysisBy admin

This paper estimates the savings opportunity from biosimilars in the medical benefit of a large employer-sponsored health plan, using real-world claims data. This analysis illustrates the savings potential of biosimilars in the commercial market and highlights the important role of employer-sponsored plans in promoting biosimilar utilization.